Japan OTC Drug Deregulation Leads To Hot Price Competition
This article was originally published in PharmAsia News
Deregulation of over-the-counter drugs in Japan appears to have had the government's desired effect as stores do battle in competition over prices. One supermarket, newly allowed to sell certain OTC drugs such as painkillers and cold remedies, became the latest to join the competition by announcing it would cut prices of such products by as much as 55 percent. Drug stores, also now allowed to sell most OTC drugs without having to have a pharmacist on the premises, also have joined the battle by offering discounts and extending store hours. (Click here for more - a subscription may be required
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.